ConductScience.org, home

Paper18829751

Glycosylation of gp41 of simian immunodeficiency virus shields epitopes that can be targets for neutralizing antibodies.

Yuste E and 5 others. J Virol, 2008. Cited by 21 papers, by iCite.

Cite this record

ConductScience Library. Glycosylation of gp41 of simian immunodeficiency virus shields epitopes that can be targets for neutralizing antibodies. Papers, record 18829751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/18829751

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Glycosylation of gp41 of simian immunodeficiency virus shields epitopes that can be targets for neutralizing antibodies.
PubMed
Journal
J Virol
PubMed
Year
2008
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
21
iCite
Relative citation ratio, by iCite
0.42
iCite
Revised in PubMed
2025-05-29
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yuste EEloìsa
2Bixby JJacqueline
3Lifson JJeffrey
4Sato SShuji
5Johnson WWelkin
6Desrosiers RRonald

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, ViralMajor topic
EpitopesMajor topic
Gene Products, envMajor topic
Simian Immunodeficiency VirusMajor topic
Amino Acid Sequence
Animals
Cell Line
Cell Membrane
Conserved Sequence
Evolution, Molecular
Glycosylation
Humans
Kinetics
Macaca mulatta
Molecular Sequence Data
Mutation
Sequence Alignment
Virus Replication

Source PubMed

Download CSV of topics

Grants15

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 AI057039NIAID NIH HHSUnited StatesR01AI057039PubMed and NIHNIH RePORTER
RR00168NCRR NIH HHSUnited StatesK26RR000168PubMed and NIHNIH RePORTER
R37 AI025328NIAID NIH HHSUnited StatesR01AI025328PubMed and NIHNIH RePORTER
R01 AI025328NIAID NIH HHSUnited StatesR01AI025328PubMed and NIHNIH RePORTER
N01 CO012400NCI NIH HHSUnited StatesN01CO012400PubMedNIH RePORTER
AI150421NIAID NIH HHSUnited StatesPubMedPubMed
AI025328NIAID NIH HHSUnited StatesR01AI025328PubMed and NIHNIH RePORTER
AI057039NIAID NIH HHSUnited StatesR01AI057039PubMed and NIHNIH RePORTER
N01-CO-12400NCI NIH HHSUnited StatesPubMedPubMed
P51 RR000168NCRR NIH HHSUnited StatesK26RR000168PubMed and NIHNIH RePORTER
K26 RR000168NCRR NIH HHSUnited StatesK26RR000168PubMed and NIHNIH RePORTER
P06RR000168NIHNIH RePORTER
P40RR000168NIHNIH RePORTER
P51RR000168NIHNIH RePORTER
R37AI025328NIHNIH RePORTER

Download CSV of grants

References35

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110888615
V2 loop glycosylation of the human immunodeficiency virus type 1 SF162 envelope facilitates interaction of this protein with CD4 and CCR5 receptors and protects the virus from neutralization by anti-V3 loop and anti-CD4 binding site antibodies.
J Virol2000https://conductscience.org/library/papers/10888615PubMed
29623976A role for carbohydrates in immune evasion in AIDS.Nat Med1998https://conductscience.org/library/papers/9623976PubMed
311070015Resistance of native, oligomeric envelope on simian immunodeficiency virus to digestion by glycosidases.J Virol2000https://conductscience.org/library/papers/11070015PubMed
411160699Mucosal transmission and induction of simian AIDS by CCR5-specific simian/human immunodeficiency virus SHIV(SF162P3).J Virol2001https://conductscience.org/library/papers/11160699PubMed
511160708Increased neutralization sensitivity of CD4-independent human immunodeficiency virus variants.J Virol2001https://conductscience.org/library/papers/11160708PubMed
611238869Loss of a single N-linked glycan allows CD4-independent human immunodeficiency virus type 1 infection by altering the position of the gp120 V1/V2 variable loops.J Virol2001https://conductscience.org/library/papers/11238869PubMed
711293117The antiviral activity of antibodies in vitro and in vivo.Adv Immunol2001https://conductscience.org/library/papers/11293117PubMed
811448167Characterization of the cis-acting elements controlling subgenomic mRNAs of citrus tristeza virus: production of positive- and negative-stranded 3'-terminal and positive-stranded 5'-terminal RNAs.Virology2001https://conductscience.org/library/papers/11448167PubMed
911581387Role of CD8(+) lymphocytes in control of simian immunodeficiency virus infection and resistance to rechallenge after transient early antiretroviral treatment.J Virol2001https://conductscience.org/library/papers/11581387PubMed
1011689624Conserved, N-linked carbohydrates of human immunodeficiency virus type 1 gp41 are largely dispensable for viral replication.J Virol2001https://conductscience.org/library/papers/11689624PubMed
1111932385Role of N-linked glycans in a human immunodeficiency virus envelope glycoprotein: effects on protein function and the neutralizing antibody response.J Virol2002https://conductscience.org/library/papers/11932385PubMed
1212477842Importance of B-cell responses for immunological control of variant strains of simian immunodeficiency virus.J Virol2003https://conductscience.org/library/papers/12477842PubMed
1312646921Antibody neutralization and escape by HIV-1.Nature2003https://conductscience.org/library/papers/12646921PubMed
1412941910Assorted mutations in the envelope gene of simian immunodeficiency virus lead to loss of neutralization resistance against antibodies representing a broad spectrum of specificities.J Virol2003https://conductscience.org/library/papers/12941910PubMed
1515016849N-linked glycosylation of the V3 loop and the immunologically silent face of gp120 protects human immunodeficiency virus type 1 SF162 from neutralization by anti-gp120 and anti-gp41 antibodies.J Virol2004https://conductscience.org/library/papers/15016849PubMed
162538547Role of N-linked glycans in the interaction between the envelope glycoprotein of human immunodeficiency virus and its CD4 cellular receptor. Structural enzymatic analysis.J Exp Med1989https://conductscience.org/library/papers/2538547PubMed
171548752Complex determinants of macrophage tropism in env of simian immunodeficiency virus.J Virol1992https://conductscience.org/library/papers/1548752PubMed
181515210Study of the interaction of HIV-1 and HIV-2 envelope glycoproteins with the CD4 receptor and role of N-glycans.AIDS Res Hum Retroviruses1992https://conductscience.org/library/papers/1515210PubMed
198317093Evidence for the cooperation of gp120 amino acids 322 and 448 in SIVmac entry.Virology1993https://conductscience.org/library/papers/8317093PubMed
208122371An N-glycan within the human immunodeficiency virus type 1 gp120 V3 loop affects virus neutralization.Virology1994https://conductscience.org/library/papers/8122371PubMed

See all 35 referencesDownload CSV of references

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.

PMIDTitleJournalYearIn PapersSource
34830279A Comprehensive Analysis of Human Endogenous Retroviruses HERV-K (HML.2) from Teratocarcinoma Cell Lines and Detection of Viral Cargo in Microvesicles.Int J Mol Sci2021https://conductscience.org/library/papers/34830279PubMed
32256496Long-Term Delivery of an Anti-SIV Monoclonal Antibody With AAV.Front Immunol2020https://conductscience.org/library/papers/32256496PubMed
30814513Rationally designed carbohydrate-occluded epitopes elicit HIV-1 Env-specific antibodies.Nat Commun2019https://conductscience.org/library/papers/30814513PubMed
30566493Guiding the humoral response against HIV-1 toward a MPER adjacent region by immunization with a VLP-formulated antibody-selected envelope variant.PLoS One2018https://conductscience.org/library/papers/30566493PubMed
29343575High-Resolution Sequencing of Viral Populations during Early Simian Immunodeficiency Virus Infection Reveals Evolutionary Strategies for Rapid Escape from Emerging Env-Specific Antibody Responses.J Virol2018https://conductscience.org/library/papers/29343575PubMed
28747495Human Immunodeficiency Virus and Simian Immunodeficiency Virus Maintain High Levels of Infectivity in the Complete Absence of Mucin-Type O-Glycosylation.J Virol2017https://conductscience.org/library/papers/28747495PubMed
23616655
Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design.
J Virol2013https://conductscience.org/library/papers/23616655PubMed
22993152Neutralizing capacity of monoclonal antibodies that recognize peptide sequences underlying the carbohydrates on gp41 of simian immunodeficiency virus.J Virol2012https://conductscience.org/library/papers/22993152PubMed
22933282A novel assay for antibody-dependent cell-mediated cytotoxicity against HIV-1- or SIV-infected cells reveals incomplete overlap with antibodies measured by neutralization and binding assays.J Virol2012https://conductscience.org/library/papers/22933282PubMed
22072749Evidence against extracellular exposure of a highly immunogenic region in the C-terminal domain of the simian immunodeficiency virus gp41 transmembrane protein.J Virol2012https://conductscience.org/library/papers/22072749PubMed
21909262Envelope deglycosylation enhances antigenicity of HIV-1 gp41 epitopes for both broad neutralizing antibodies and their unmutated ancestor antibodies.PLoS Pathog2011https://conductscience.org/library/papers/21909262PubMed
21165339Functional contributions of carbohydrate on AIDS virus glycoprotein.Yale J Biol Med2010https://conductscience.org/library/papers/21165339PubMed
21067547Models of RNA virus evolution and their roles in vaccine design.Immunome Res2010https://conductscience.org/library/papers/21067547PubMed
20702641Envelope-modified single-cycle simian immunodeficiency virus selectively enhances antibody responses and partially protects against repeated, low-dose vaginal challenge.J Virol2010https://conductscience.org/library/papers/20702641PubMed
20610711Fundamental difference in the content of high-mannose carbohydrate in the HIV-1 and HIV-2 lineages.J Virol2010https://conductscience.org/library/papers/20610711PubMed
20055586Short communication: Simultaneous substitutions of V38M and N43T-N44K in the gp41 heptad repeat 1 (HR1) disrupt HIV type 1 gPr160 endoproteolytic cleavage (*).AIDS Res Hum Retroviruses2010https://conductscience.org/library/papers/20055586PubMed
19610667Glycosylation site-specific analysis of clade C HIV-1 envelope proteins.J Proteome Res2009https://conductscience.org/library/papers/19610667PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/18829751

GET https://conductscience.org/api/papers/v1/18829751/references?page=2